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Objective. To compare oxidative stress following spontaneous vaginal delivery with that induced by Oxytocin augmented delivery.
Methods. 98 women recruited prior to labor. 57 delivered spontaneously, while 41 received Oxytocin for augmentation of labor.
Complicated deliveries and high-risk pregnancies were excluded. Informed consent was documented. Arterial cord blood gases,
levels of Hematocrit, Hemoglobin, and Bilirubin were studied. Glutathione (GSH) concentration was measured by a spectroscopic
method. Plasma and red blood cell (RBC) levels of Malondialdehyde indicated lipid peroxidation. RBC uptake of phenol red
denoted cell penetrability. SPSS data analysis was used. Results. Cord blood GSH was signiﬁcantly lower in the Oxytocin group
(2.3 ± 0.55mM versus 2.55 ± 0.55mM, P = .01). No diﬀerences were found in plasma or RBC levels of MDA or in uptake
of Phenol red between the groups. Conclusion. Lower GSH levels following Oxytocin augmentation indicate an oxidative stress,
though selected measures of oxidative stress demonstrate no cell damage.
Copyright © 2009 Naomi Schneid-Kofman et al. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
1.Introduction
Labor is a state of stress, though the oxidative burden upon
the fetus is of controversy in literature [1, 2]. Neonatal
adverse outcome may result from oxidative stress, thus cord
blood pH is currently the most used method for assessing
fetal oxidative metabolic stress with some correlation to
neonatal outcome [3, 4].
Reactive oxygen free radicals are produced by aerobic cell
metabolic activity. The accumulation of these radicals can
produce toxic changes within the cells by an uncontrolled
self-enhancing process of lipid peroxidation of membranes
and inner cell components resulting in a disruption of
membrane lipids and other cell components. The cell defen-
sive system consists of antioxidative free-radical scavenging
moleculessuchasglutathione(GSH—atripeptideconsisting
of glutamic acid-cysteine-glycine). GSH acts as the substrate
for the enzyme glutathione peroxidase. As such it is an
important component of intracellular antioxidant defense,
protecting cytosolic organelles, in particular, from the dam-
aging eﬀects of hydroperoxides. In addition, GSH also acts
synergistically with ascorbic acid and alphatocopherol to
recycle these nutrient antioxidant vitamins to their reduced
state after their interaction with reducing chemical species
inside the cell [5].
Red blood cells (RBCs) are prone to lipid peroxida-
tion by virtue of their function as oxygen carriers and
their lipid composition. Measurement of Malondialdehyde
(MDA) content using thiobarbituric reagent is widely used
toquantifylipidperoxidationandisindicativeoftheamount
of oxygen radicals in the RBC environment. An alternative
method of evaluating lipid peroxidation in RBC is by
measuring uptake of phenol red [6].
Initiation and progress of labor are generated by endoge-
nous Oxytocin hormone levels. Low contraction frequency
and protracted labor are treated with administration of
exogenous Oxytocin for augmenting labor [7].2 Obstetrics and Gynecology International
Uterine blood ﬂow is reduced during contractions and
further reduced during intensive uterine activity, resulting
in compromised placental blood ﬂow. Therefore, adminis-
tration of Oxytocin during labor may induce fetal oxidative
stress. Previous studies have found no adverse eﬀect of
Oxytocin treatment on pH levels [8], and Oxytocin augmen-
tation did not increase perinatal risk [9]. Measuring the level
of antioxidation enzymes in cord blood following Oxytocin
treatment provides useful information regarding the extent
of fetal oxidative stress and the information regarding the
safe use of this treatment in labor.
In this study, we compared the oxidative stress induced
by normal vaginal delivery with that following Oxytocin
augmented delivery.
2.MaterialsandMethods
Prior to delivery, 98 women were recruited from labor
and delivery department in Soroka medical center dur-
ing November 2006 and February 2007. Of these, 57
delivered uncomplicated spontaneous vaginal deliveries; 41
received Oxytocin treatment (Oxytocin Injection, BP 10
Units/ampule, produced by Rotexmedica GmbH, Germany)
for augmentation of labor resulting in vaginal delivery. Four
women of the control group and one of the Oxytocin group
were excluded during data analysis, all for incomprehensive
lab analysis (hemolytic sample, coagulated sample). The
protocol of treatment in our institution for Oxytocin
administration was followed. Oxytocin was diluted at 5mIU
in 500mL NaCl 0.9%, administered at an initial rate of
2mIU/min and increased by 2mIU every 20–40 minutes,
until eﬀective regular contractions were achieved. The
maximum dose administered was 16mIU/min. Dose and
duration of therapy were documented. The ﬁnal appropriate
dose administered was determined by observed frequency of
resulting uterine contractions and by progress of labor.
Excluded from the study were multifetal deliveries,
surgical or mechanical deliveries, Postdate deliveries (42
completed weeks of pregnancy), or suspected intrauterine
growth restricted fetuses.
Data were collected by personal interviews, validated
through medical records. We collected data regarding demo-
graphics, past medical and obstetric history, the indication
foraugmentationoflabor,durationoflabor(ﬁrstandsecond
stages), neonatal data, and use of epidural anesthesia.
Blood samples were drawn from the umbilical cord
artery immediately after fetal delivery, before delivery of the
placenta and stored at 4◦C, up to 8 hours. Whole blood
samples were analyzed within ﬁve minutes of collection by a
blood gas analyzer for pH, carbon dioxide (pCO2), oxygen
(pO2), oxygen saturation, and base excess (BE). Levels
of Hematocrit, Hemoglobin, and Bilirubin were analyzed
within an hour of delivery. Measurements of oxidative stress
indicators were concluded within eight hours. Glutathione
concentration was determined by a spectroscopic method,
measuring the production of the yellow anion produced
by redox reaction between sulphahydryl (–SH) groups and
the reagent 5,5
 -Dithiobis-2-nitrobenzoic acid (DTNB) [10].
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Figure 1: GSH level by Oxytocin treatment.
Plasma and red blood cell (RBC) levels of Malondialdehyde
(MDA) were measured for lipid peroxidation; RBC uptake
of phenol red was measured for cell penetrability [6].
Measurements of penetrability are displayed as arbitrary
units of absorption.
Statistical analysis was performed with an SPSS software
package (SPSS, Chicago, IL). Statistical signiﬁcance was
determined using the χ2 test, the Fisher exact test for
diﬀerences between qualitative variables, and the t-test for
diﬀerences between continuous variables. Odds ratios (OR)
and their 95% conﬁdence intervals (CI) were calculated.
Pearson correlation coeﬃcient was used to calculate the
correlation of GSH on pO2. Multivariate analysis was
preformed. P<. 05 was considered statistically signiﬁcant.
This study is preliminary in the ﬁeld of Oxytocin in vaginal
delivery and oxidative stress. Due to lack of previous data,
power analysis was not done.
The study was approved by the Institutional Review
Board; informed consent was documented.
3. Results
Excluded from the data analysis were four of the control
group and one of the Oxytocin group, all for failure to attain
comprehensive lab results (hemolytic sample, coagulated
sample).
Demographic characteristics were comparable between
the groups (Table 1).
In the Oxytocin group, the dose of administered Oxy-
tocinranged2–16mIU/min,(mean9.3mIU/min).Duration
of treatment was between 1–11 hours (mean 3.7 hours). The
sole indication for treatment was augmentation of labor.
Cord blood GSH was signiﬁcantly lower in the Oxytocin
group (2.0 ± 0.55mM versus 2.3 ± 0.55mM, P = .01)
(Figure 1).
In a multivariate analysis, adjusted for numbers of
deliveries, fetal gender and fetal weight, Oxytocin remained
the main predictor for GSH (Beta = (−1.859), P = .066).
Uptake of phenol red was similar between the groups
(0.08 versus 0.076, P = .11). No diﬀerences were found
betweenthegroupsinlevelsofMDAinplasma(0.9±0.03μMObstetrics and Gynecology International 3
Table 1: Demographic characteristics.
With Oxytocin
(mean±Standard deviation) n = 40
Without Oxytocin
(mean±Standard deviation) n = 53
P
Maternal age (years) 26.9 ±5.62 8 .5 ±5.7 P = .18
Pregnancy order 2.9 ±24 .1 ±2 P = .01
Delivery number 1.6 ±22 .6 ±2 P = .03
Gestational age (weeks) 39.0 ±1.43 9 .5 ±1.3 P = .09
Birth weight (g) 3207 ±350 3308 ±405 P = .202
Table 2: Cord blood characteristics.
With Oxytocin
(mean±Standard deviation) n = 53
Without Oxytocin
(mean±Standard deviation) n = 40
P
pH 7.31 ±0.06 7.33 ± 0.06 P = .15
pO2 mmHg 36 ±17 35 ± 21 P = .83
pCO2 mmHg 40 ±10 40 ±9 P = .94
Base excess (−5.2) ±2.2( −4.6) ±2.1 P = .16
versus 0.97 ± 0.05μM, P = .1) or MDA levels in RBC
(2.05 ±0.16μMv e r s u s1 .93 ±0.10μM, P = .23).
CordbloodgascharacteristicsaresummarizedinTable 2.
Comparingthegroups,signiﬁcantdiﬀerenceswerenoted
regarding length of delivery. First stage was signiﬁcantly
longeramongtheOxytocingroup(361±267minutes.versus
172 ± 130minutes. P<. 001) as was second stage of labor
(25 ±28minutes. versus 13 ±12minutes. P = .01). Epidural
anesthesia was more prevalent in the Oxytocin group (15%
versus 4%, P = .05). No diﬀerence was noted in meconium
stained amniotic ﬂuid (15% versus 12%, P = .61) between
the groups.
ComparisonofGSHlevelsamongﬁrstdeliveriesbetween
the groups demonstrated a lower level of GSH following
Oxytocin treatment (2.18±0.40mM versus 2.79±0.17mM,
P = .002). The length of second stage of labor was similar
in ﬁrst deliveries in both groups (41 ± 38minutes. versus
44 ±25minutes, P = .85).
As many as 63% of women from Oxytocin group were
treated by iron supplements during pregnancy, while 72%
received iron supplementation in the control group, P = .35.
No correlation was found between iron treatment and GSH
levels (correlation signiﬁcance 0.73).
None received vitamin formulas during the last week
before delivery. Two women from the Oxytocin group
smoked during the pregnancy while none smoked in the
control group, P = .1. The participants were questioned
regarding disease prevalence. Gestational diabetes treated by
diet alonewasnotedintwowomenfromtheOxytocingroup
and in none from the control group, P = .1. No hypertensive
disorders were detected. None had G6PD deﬁciency.
Obstetrichistorywasexaminedfordetectionofhigh-risk
pregnancies. No signiﬁcant diﬀerences were noted between
the Oxytocin and the control group regarding previous
preterm labor (0.07±0.2v e r s u s0 .1±0.5, P = .47), previous
early abortion (0.2±0.5v e r s u s0 .3±0.7, P = .6), or previous
cesarean section (0 ± 0v e r s u s0 .07 ± 0.2, P = .07). No
diﬀerence was found regarding prenatal care between the
groups, the Oxytocin group 2.7 ± 0.5 (in a scale of 1–3, 1
= lack of care, 3 = complete prenatal care) and 2.5 ± 0.6f o r
the control group, P = .2.
4. Discussion
Oxytocin augmentation of labor is an acceptably safe
modality of treatment. Lower Glutathione levels compared
to normal vaginal delivery indicate oxidative stress, yet no
fetalredbloodcelldamageisinstituted.TheRBCantioxidant
systemssuﬃcetopreventcelldamageoflipidperoxidationor
increased permeability of the RBC membrane. Higher levels
of GSH that are noted in the newborn according to previous
publications [11] may contribute to an enhanced defensive
mechanism against oxidative stress in the neonate [12]. pH
levels were similar between the groups, in accordance with
previous publications [8].
Oxytocin dose tapering is determined by frequency of
contractions and labor progression, thus, the same drug
dose might induce a diﬀerent frequency of contractions
in diﬀerent patients as well as dissimilar rates of oxidative
stress. Consistent with the local protocol of treatment by
Oxytocin, frequency of contractions was maintained at less
than ﬁve contractions in ten minutes. Dose of oxytocin was
adjusted as needed to attain this goal. Quantiﬁcation of
Oxytocin treatment for the purpose of precise comparison
between the groups was of concern due to the short half
life of this hormone and the debate whether the total dose
administered during labor or the last dosage of treatment
is the most accurate indicator of the Oxytocin impact.
Provided that a drug with short term eﬀect administered
hours prior to a measured oxidative reaction which is quick
and changing in nature has questionable eﬀect upon the
outcome, the last dose administered was chosen as the index
of treatment.
Direct measurements of Oxytocin in maternal blood
might have improved the precision of our results though4 Obstetrics and Gynecology International
othershavefailedtodemonstrateacorrelationbetweenmea-
sured blood Oxytocin concentration and fetal pH [8, 13, 14].
In the Oxytocin group, primiparity was more prevalent.
Length of second stage of labor among primiparas was not
signiﬁcantly diﬀerent between the groups (41 ± 38minutes.
versus 44 ± 25minutes, P = .85). These parameters support
the observation that GSH was lower in the study group due
to Oxytocin treatment and not due to longer ﬁrst deliveries.
There is some evidence that the detected impact of Oxytocin
upon GSH levels might become substantial in compromised
fetuses [15, 16].
The correlation between Oxytocin level and lower GSH
is not supported by lower GSH levels found during elective
cesarean deliveries compared to vaginal deliveries [17]; this
inconsistency may evolve from higher oxidative stress caused
by the operative delivery and anesthesia process and not
attributed to the labor-induced Oxytocin level. A study com-
paring fetal oxidative stress following elective and emergent
cesarean sections demonstrated higher oxidative stress in
emergent cesarean deliveries (increased MDA levels); the
author implied in this case that the mode of delivery was
notthemainattributortooxidativestressbutratherprevious
fetal condition [18]. This remains to be further explored.
In conclusion, Oxytocin treatment for augmentation of
low-risk vaginal deliveries contributes to oxidative stress;
however, no fetal cell damage is induced. Higher-power
studies are required to further establish these ﬁndings.
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